DexCom, Inc.
Market cap $33.2B
$89.60
DXCM
$89.60
+0.28% today
Buy with €1M virtual cash · No real money
DexCom, Inc. (DXCM) is a publicly traded company listed on the XNAS. As of September 19, 2026, Invest's signal rates DXCM a Buy, with the stock up 17% over the past year. You can practice trading DXCM risk-free with €1,000,000 in virtual cash.
Key stats
As of September 19, 2026
Market Cap
$33.2B
Volume
14.6M
52-wk High
$92.59
52-wk Low
$54.11
Day High
$89.92
Day Low
$87.39
P/E (TTM)
35.56
Revenue (TTM)
$5.0B
EPS (TTM)
$2.52
Performance
1M
-0.3%
6M
+33.2%
1Y
+17.2%
Invest signal · DXCM
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
DXCM overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +9.8%Revenue
$1BEPS (diluted)
$0.64 per shareLatest DXCM news
Here's How Much a $1000 Investment in DexCom Made 10 Years Ago Would Be Worth Today
Zacks Investment Research · Aug 31
Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights
GlobeNewswire Inc. · Jul 14
3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound
Investing.com · Jun 18
Dexcom Scores Pediatric Expansion For OTC Stelo Glucose Monitor
Benzinga · Jun 15
[Latest] Non-Invasive Blood Glucose Monitoring Devices Market Size to Hit USD 340.49 Million with a Promising CAGR of 25.60% by 2034 - Report by Zion Market Research (ZMR)
GlobeNewswire Inc. · Jun 4
About DexCom, Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Employees
11,100
30-Day Win Rate · DXCM
14 days
9 days
Last 23 sessions
How to practice trading DXCM
- 1
Use the DXCM buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top DXCM traders on Invest
Full leaderboardFrequently asked questions
Is DXCM a good stock to buy right now?
As of September 19, 2026, Invest's signal rates DXCM a Buy, based on its price trend, valuation, and fundamentals (P/E around 35.6), with the stock up 17% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading DXCM risk-free first.
What is DexCom, Inc.'s (DXCM) market cap?
DexCom, Inc. has a market capitalization of approximately $33.2B, on trailing-twelve-month revenue of about $5.0B.
How has DXCM stock performed?
DXCM is up 17% over the past year and up 33% over six months. Its 52-week range runs roughly from $54.11 to $92.59. Past performance doesn't predict future results.
How can I practice trading DXCM for free?
On Invest you get €1,000,000 in virtual cash and can buy DXCM at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare DXCM with peers